182 related articles for article (PubMed ID: 23937883)
21. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
[TBL] [Abstract][Full Text] [Related]
22. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation.
Atkins BZ; Hashmi ZA; Ganapathi AM; Harrison JK; Hughes GC; Rogers JG; Milano CA
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1247-52. PubMed ID: 23870154
[TBL] [Abstract][Full Text] [Related]
23. Aortic valve procedures at the time of ventricular assist device placement.
Goda A; Takayama H; Pak SW; Uriel N; Mancini D; Naka Y; Jorde UP
Ann Thorac Surg; 2011 Mar; 91(3):750-4. PubMed ID: 21352992
[TBL] [Abstract][Full Text] [Related]
24. A novel link between G6PD deficiency and hemolysis in patients with continuous-flow left ventricular assist devices.
Alhosaini H; Jensen BC; Chang PP; Sheridan BC; Katz JN
J Heart Lung Transplant; 2014 Jan; 33(1):116-7. PubMed ID: 24290168
[No Abstract] [Full Text] [Related]
25. Percutaneous treatment of severe aortic insufficiency in a patient with left ventricular assist device: friend or foe.
Zacharias M; Dhingra R
JACC Cardiovasc Interv; 2015 Apr; 8(5):750-1. PubMed ID: 25946449
[No Abstract] [Full Text] [Related]
26. Safety of discontinuation of anti-coagulation in patients with continuous-flow left ventricular assist devices.
Kamdar F; Eckman P; John R
J Heart Lung Transplant; 2014 Mar; 33(3):316-8. PubMed ID: 24462558
[No Abstract] [Full Text] [Related]
27. Opening of Aortic Valve During Exercise Is Key to Preventing Development of Aortic Insufficiency During Ventricular Assist Device Treatment.
Imamura T; Kinugawa K; Nitta D; Hatano M; Ono M
ASAIO J; 2015; 61(5):514-9. PubMed ID: 25955152
[TBL] [Abstract][Full Text] [Related]
28. Novel application of Angiojet rheolytic thrombectomy for massive thrombosis of the native aortic valve and Jarvick 2000 ventricular assist device in a patient with end-stage heart failure.
Barbieri A; Bertelli L; Sangiorgi GM
Catheter Cardiovasc Interv; 2011 Nov; 78(6):958-61. PubMed ID: 21805566
[TBL] [Abstract][Full Text] [Related]
29. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support.
Shah P; Mehta VM; Cowger JA; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):102-4. PubMed ID: 23968811
[No Abstract] [Full Text] [Related]
31. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
33. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous closure of an incompetent aortic valve using an occluder device in a patient with left ventricular assist device.
Feider A; Dhawan R; Chaney M
Anesth Analg; 2013 Nov; 117(5):1078-80. PubMed ID: 24029857
[No Abstract] [Full Text] [Related]
35. Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation.
Sandner SE; Riebandt J; Haberl T; Mahr S; Rajek A; Schima H; Wieselthaler GM; Laufer G; Zimpfer D
J Heart Lung Transplant; 2014 Jan; 33(1):88-93. PubMed ID: 24239003
[TBL] [Abstract][Full Text] [Related]
36. Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients.
McIlvennan CK; Page RL; Ambardekar AV; Brieke A; Lindenfeld J
J Heart Lung Transplant; 2014 Dec; 33(12):1312-4. PubMed ID: 25443872
[No Abstract] [Full Text] [Related]
37. Complications of Durable Left Ventricular Assist Device Therapy.
Emani S
Crit Care Clin; 2018 Jul; 34(3):465-477. PubMed ID: 29907277
[TBL] [Abstract][Full Text] [Related]
38. Unforeseen consequences of therapy with continuous-flow pumps.
Frazier OH
Circ Heart Fail; 2010 Nov; 3(6):647-9. PubMed ID: 21081738
[No Abstract] [Full Text] [Related]
39. Monitoring of aortic valve opening and systolic aortic insufficiency in optimization of continuous-flow left ventricular assist device settings.
Gologorsky E; Gologorsky A; Pham SM
J Cardiothorac Vasc Anesth; 2012 Dec; 26(6):1063-6. PubMed ID: 22959842
[No Abstract] [Full Text] [Related]
40. Transcatheter aortic valve replacement performed via left ventricular assist device inflow cannula.
Vavalle JP; Kiefer TL; Milano CA; Harrison JK; Hughes GC
Circ Heart Fail; 2014 May; 7(3):544-6. PubMed ID: 24847132
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
